ABSTRACT
We explored the impacts of nitrogen (N) reduction and biochar application on soil fertility and nutrient uptake of rice in early and late seasons of 2018 with a field experiment. There were six treatments, including control (no N application, CK), conventional N application (N100), 20% N reduction (N80), 20% N reduction plus biochar application (N80+BC), 40% N reduction (N60), 40% N reduction plus biochar application (N60+BC). Our results showed that 20% and 40% N reduction and/or with biochar application did not affect soil pH, organic matter, total N, total phosphorous (P), total potassium (K), ammonium N, available P and K in comparison with N100 treatment. N80+BC and N60+BC substantially increased soil cation exchange capacity (CEC) at tillering stage and electrical conductivity (EC) at heading stage in late season, respectively. Compared with the treatment with single N reduction, N80+BC significantly increased soil available K in early and late seasons and soil pH and total N in late season, while N60+BC increased soil total K at mature stage in early season. Soil nitrate content was decreased along with the growth stages for all treatments in early season. Compared with tillering stage, soil nitrate N content in conventional N application at heading stage and mature stage was decreased by 50.0% and 71.6%, respectively. Soil nitrate content in biochar treatment only was decreased by 6.3%-45.5%. N application along with biochar application had no significant effects on plant N uptake and utilization in early season. However, N reduction with biochar application significantly increased plant N uptake and N utilization rate by 34.8%-52.4% in late season, compared to conventional N application and single N reduction. Our findings suggest that adequate N reduction along with biochar application could maintain soil health and improve plant N uptake and utilization efficiency.
Subject(s)
Fertilizers/analysis , Oryza , Charcoal , Nitrogen , Nutrients , SoilABSTRACT
AIM: To explore the relationship among interferon-gamma (IFN-gamma) activity, fibrogenesis, T cell immune responses and hepatic inflammatory activity. METHODS: Peripheral blood samples from a total of 43 hepatitis B cirrhotic patients (LC) and 19 healthy controls (NC) were collected to measure their serum levels of IFN-gamma, interleukin-2 (IL-2), soluble interleukin-2 receptor (sIL-2R), interleukin-10 (IL-10) and three serological markers of fibrosis including hyaluronic acid (HA), procollagen type III peptide (PIIIP), and type IV collagen were measured using a double antibody sandwich ELISA. Also, serum total bilirubin (TB) and alanine aminotransferase (ALT) were measured by routine measures. RESULTS: The concentrations of serological markers of fibrosis in patients with active cirrhosis (ALC) were significantly higher than those in stationary liver cirrhosis (SLC) or NC groups. The levels of serological markers in HBeAg-positive patients were significantly higher than those in HBeAg-negative patients. In SLC and ALC patients, a negative linear correlation was found between IFN-gamma levels and the serological markers of fibrosis. IFN-gamma and IL-2 levels in the ALC group were significantly higher than those in the SLC and NC groups, but the statistical difference was not significant between the latter two. In contrast, IL-10 levels in the SLC group were significantly higher than that in the NC group, but no significant difference was found between SLC and ALC groups. The sIL-2R level was elevated gradually in all these groups, and the differences were significant. Positive linear correlations were seen between IFN-gamma activity and ALT levels (r = 0.339, P < 0.05), and IL-2 activity and TB levels (r = 0.517, P < 0.05). sIL-2R expression was positively correlated with both ALT and TB levels (r = 0.324, 0.455, P < 0.05), whereas there was no statistically significant correlation between IL-10 expression and serum ALT and TB levels (r = -0.102, -0.093, P > 0.05). Finally, there was a positive correlation between IFN-gamma and IL-2 levels. CONCLUSION: T cell immune responses are correlated with fibrosis and hepatic inflammatory activity and may play an important role in liver cirrhosis.